Assoc Prof Dr. Yu-Huei LIu, China Medical University, Taiwan
Assoc. Prof. Dr. Yu-Huei Liu is an Associate Professor at China Medical University, Taiwan. She specializes in the field of [insert specific research area or department, if known, e.g., “pharmacology” or “biomedical sciences”]. Dr. Liu has a distinguished academic background, having completed her Ph.D. at [insert institution, if known] with a focus on [insert research focus, if known]. Her research interests encompass [insert specific research interests, e.g., “drug development,” “molecular mechanisms of disease,” etc.], and she has contributed significantly to the field through numerous publications in high-impact journals. Dr. Liu is recognized for her dedication to advancing medical science and her role in mentoring future researchers.
Education:
Assoc. Prof. Dr. Yu-Huei Liu earned her Bachelor of Science degree in Medical Technology from Taipei Medical College in 1999. She continued her academic journey at National Taiwan University, where she completed her Master’s and Ph.D. in Biochemistry and Molecular Biology, finishing in 2000 and 2008, respectively. Dr. Liu furthered her expertise through a postdoctoral fellowship in the same field at National Taiwan University from 2008 to 2009. Her comprehensive educational background equips her with deep insights into biochemistry and molecular biology, underpinning her significant contributions to research and academia.
Assoc. Prof. Dr. Yu-Huei Liu at China Medical University, Taiwan, is a leading researcher in cancer biology, with a focus on pancreatic and breast cancer functional genomics. Her lab combines cellular culture techniques, genetic and protein analysis, and animal experimentation to explore cancer progression pathways. Dr. Liu’s research aims to uncover novel biomarkers and therapeutic targets by studying specific genes and proteins involved in cancer initiation and progression. Embracing a multidisciplinary approach, her lab integrates artificial intelligence for data mining and analysis, enhancing their ability to derive insights from complex biological data. Dr. Liu’s work is dedicated to advancing cancer treatment strategies and improving the quality of life for cancer survivors.
Assoc. Prof. Dr. Yu-Huei Liu has received numerous accolades for her contributions to cancer research and education. Notable awards include the Excellent Thesis Prize from National Taiwan University’s Medical College in 2009, and multiple Best Teacher Awards from the Institute of Integrated Medicine at China Medical University in 2012 and 2014. She has been recognized for her scientific presentations, including an invited talk at the 14th Cross-strait Biomedical Conference in 2015 and the 25th East Asia Joint Symposium on Biomedical Research in 2018. Dr. Liu also earned the Best Poster Award at the 32nd International Symposium on Natural Products in 2017 and presented at prestigious conferences such as the Gordon Research Conference on Pancreatic Diseases in 2019. Additionally, she served as a Visiting Scholar at the Genome Research Center, Academia Sinica, Taiwan, from January to June 2020.
Top Notable Publications:
Huang, C.-Y., & Liu, Y.-H. (2024). Sex difference, proteostasis and mitochondrial function impact stroke-related sarcopenia—A systematic review and meta-analysis. Ageing Research Reviews, 101, 102484. [Link Disabled]
Liu, Y.-H., Hu, C.-M., Hsu, Y.-S., & Lee, W.-H. (2022). Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma. Cell Death and Disease, 13(9), 817. [Link Disabled]
Lee, J.-Y., Liao, W.-L., Liu, Y.-H., Lung, F.-W., & Hsieh, C.-L. (2022). Oral administration of processed Cassia obtusifolia L. seed powder may reduce body weight and cholesterol in overweight patients with schizophrenia: A 36-week randomized, double-blind, controlled trial of high and low doses. Journal of Ethnopharmacology, 292, 115111. [Link Disabled]
Tsai, C.-L., Liu, L.-C., Liao, C.-Y., Liu, Y.-H., & Hsieh, C.-L. (2021). Yoga versus massage in the treatment of aromatase inhibitor-associated knee joint pain in breast cancer survivors: A randomized controlled trial. Scientific Reports, 11(1), 14843. [Link Disabled]
Tsai, C.-H., Lin, Y.-H., Li, Y.-S., Thuong, L.H.H., & Liu, Y.-H. (2021). Integrated medicine for chemotherapy-induced peripheral neuropathy. International Journal of Molecular Sciences, 22(17), 9257. [Link Disabled]
Tsai, L.-H., Hsu, K.-W., Chiang, C.-M., Cheng, W.-C., Wu, H.-H., & Liu, Y.-H. (2020). Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer. Scientific Reports, 10(1), 17817. [Link Disabled]
Chen, T.-F., Hsu, J.-T., Wu, K.-C., Cho, D.-Y., Hsu, J.-L., & Liu, Y.-H. (2020). A systematic identification of anti-inflammatory active components derived from Mu Dan Pi and their applications in inflammatory bowel disease. Scientific Reports, 10(1), 17238. [Link Disabled]
Liu, Y.-H., Shen, C.-Y., & Tsai, F.-J. (2020). Association of variant on the promoter of cluster of differentiation 74 in Graves disease and Graves ophthalmopathy. Bioscience Reports, 40(8), BSR20202072. [Link Disabled]
Su, C.I., Kao, Y.-T., Chang, C.-C., Liu, Y.-H., & Yu, C.-Y. (2020). DNA-induced 2’3′-cGAMP enhances haplotype-specific human STING cleavage by dengue protease. Proceedings of the National Academy of Sciences of the United States of America, 117(27), pp. 15947–15954. [Link Disabled]
Jhang, K.-M., Wang, W.-F., Chang, H.-F., Chang, M.-C., Wu, H.-H., & Liu, Y.-H. (2020). Care needs of community-residing male patients with vascular cognitive impairment. Neuropsychiatric Disease and Treatment, 16, pp. 2613–2621. [Link Disabled]